Skip to main content
Clinical Trials/TCTR20210831001
TCTR20210831001
Not Yet Recruiting
Phase 1

The effect of discharge program on preparedness and uncertainty of family members in care for patients undergoing hematopoietic cell transplantation

Dr Mohamad Ali Sahraeiyan0 sites120 target enrollmentAugust 31, 2021

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Hematopoietic cell transplantation (HSCT) Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
Sponsor
Dr Mohamad Ali Sahraeiyan
Enrollment
120
Status
Not Yet Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 31, 2021
End Date
April 21, 2022
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
Dr Mohamad Ali Sahraeiyan

Eligibility Criteria

Inclusion Criteria

  • family member age over 18 years old
  • Caring for the patient at home
  • Ability to speak, read and write in Persian
  • Having a smartphone and access to the Internet and social media
  • Age range 18 to 60 years for Patients undergoing HSCT
  • Patient undergoing HSCT for any reason (leukemia, lymphoma, immune problems, etc.)
  • Patient undergoing HSCT (allogeneic or autologous)
  • Hospitalization of patients under HSCT in adult wards
  • Having at least two family members involved in patient care at home

Exclusion Criteria

  • Having a distinct mental illness of a family caregiver
  • Recent critical events such as the loss of loved ones and divorce
  • Caring for another person in the family due to an underlying illness
  • Addiction of a family member based on self\-declaration
  • Withdrawal of Participants from the study
  • Long\-term hospitalization of patients (more than one month)
  • Transplant rejection
  • Death of the patient

Outcomes

Primary Outcomes

Not specified

Similar Trials